FDA Approved: ATOVAQUONE ORAL SUSPENSION — Supplemental Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA approved a supplemental application to authorize the Atovaquone oral suspension produced by KVK-Tech, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Babesiosis
• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• ATOVAQUONE ORAL SUSPENSION (Atovaquone oral suspension)

Snippet

SUPPL AP for ATOVAQUONE ORAL SUSPENSION (ATOVAQUONE)